Kidney-friendly eating is never one universal food list. A useful plan starts with laboratory trends, medicines, symptoms, urine findings, and the stage of kidney disease—not a single “high” or “low” result.
- eGFR staging requires persistence for at least 3 months; one low estimate after dehydration or intense exercise does not establish chronic kidney disease.
- Potasyûm of 6.0 mmol/L or higher can be dangerous, particularly with weakness, palpitations, or ECG changes, and is not a diet-plan problem to manage at home.
- Protein intake is commonly individualised around 0.6–0.8 g/kg/day for many adults with non-dialysis CKD, while dialysis usually raises needs to about 1.0–1.2 g/kg/day.
- ACR ـی ئورین of 30 mg/g or more is albuminuria and changes dietary, blood-pressure, and medication discussions even when eGFR looks preserved.
- فۆسفۆر above a laboratory upper limit near 1.45 mmol/L needs review of additives, binders, vitamin D therapy, and kidney stage—not simply avoidance of all protein foods.
- Sodyûm intake below 2 g/day, equivalent to under 5 g/day of salt, is recommended by KDIGO for most people with CKD unless a clinician gives a different target.
- AI nutritionist recommendations should use repeated lab values and medication data, then be checked by the renal clinician or renal dietitian before meaningful restrictions.
- پرچمە سوورەکان include potassium 6.0 mmol/L or higher, rapidly falling eGFR, new severe breathlessness, confusion, chest symptoms, or markedly reduced urine output.
What an AI nutritionist can safely personalize for kidney diets
Yek AI nutritionist can safely help organise kidney-friendly meal choices when it reads repeated eGFR, potassium, bicarbonate, phosphate, urine albumin, diabetes markers, and medicines together; it cannot diagnose kidney disease or replace a renal dietitian. The safe output is a provisional personalized nutrition plan with clear escalation rules, not a rigid low-potassium menu.
As of September 1, 2026, the useful role of AI is pattern recognition and practical translation: spotting that potassium has moved from 4.5 to 5.4 mmol/L after an ACE inhibitor change, then suggesting a medication-and-food review rather than blaming one banana. Kantesti ئانالیزەری تاقیکردنی خوێنی AI ـە designed to interpret laboratory context and highlight questions for clinical follow-up. Our ڕێنمایی پۆلەکانی کلیه بەراورد بکەن explains why eGFR and urine ACR belong together.
A single normal-looking renal panel is not permission to use a generic “renal diet.” In my clinical work, the people most harmed by broad restriction are often older adults who cut fruit, vegetables, dairy, and protein simultaneously, then lose weight or become constipated while their potassium was never elevated.
Dr. Thomas Klein’s practical rule is simple: an AI recommendation should state the lab date, unit, trend direction, and safety boundary. If any of those are missing, it is not individualized nutrition; it is generic wellness copy.
The right task for AI
AI can convert clinician-approved targets into shopping swaps, recipe portions, and repeat-test reminders. It should preserve cultural food preferences and flag uncertainty when laboratory timing, medication list, or dialysis status is absent.
Why eGFR is an estimate, not a diet prescription
eGFR below 60 mL/min/1.73 m² for 3 months or more supports chronic kidney disease when persistent, but it does not by itself determine potassium, fluid, or protein restrictions. eGFR estimates filtration from creatinine or cystatin C and can shift with muscle mass, diet, hydration, and some medicines.
An eGFR of 52 mL/min/1.73 m² in a muscular 35-year-old after a marathon deserves a different response from the same result in an 82-year-old with albuminuria and hypertension. Creatinine rises after strenuous exercise and dehydration can temporarily lower eGFR; see our guide to temporary eGFR changes.
KDIGO defines G3a CKD as eGFR 45–59 and G3b as 30–44 mL/min/1.73 m² when the change persists for at least 3 months (KDIGO CKD Work Group, 2024). A fall of 20% or more on repeat testing exceeds expected biological variation enough to merit review, especially after starting a kidney-active medicine.
Kantesti’s neural network treats eGFR as a trend, not a verdict. Kantesti پلاتفۆرمێکی تێکست-وەسفی تێستەکانی خوێنی AI ـە that can compare dated reports, but only the treating clinician can decide whether an apparent decline reflects CKD progression, acute illness, obstruction, medication effect, or a reporting difference between laboratories.
How potassium results change meal advice
Serum potassium of 3.5–5.0 mmol/L is typical in many adult laboratories, while 5.5 mmol/L or higher usually requires timely clinical review. Potassium restriction is appropriate only when elevation is persistent or risk is high; many people with CKD can still eat plant-forward meals safely.
Potassium is affected by kidney excretion, insulin, acid-base status, constipation, and drugs such as ACE inhibitors, ARBs, spironolactone, trimethoprim, and NSAIDs. A value of 5.7 mmol/L with bicarbonate 17 mmol/L and constipation is a different clinical picture from 5.7 after a visibly haemolysed collection; collection-related false elevation is surprisingly common.
پۆتاسیم لە 6.0 mmol/L یان بەرزتر warrants urgent same-day assessment, and emergency care is appropriate with palpitations, fainting, severe weakness, chest symptoms, or an abnormal ECG. Food changes work over days, not minutes, so an AI nutritionist must never present a recipe as treatment for severe hyperkalaemia.
The less obvious point: potassium additives in processed meat substitutes, instant drinks, and low-sodium salt substitutes can be more absorbable than potassium naturally packaged in a whole apple or lentils. A dietitian may use preparation methods such as boiling and draining vegetables, but I do not recommend blanket soaking rituals without an individual target. Read our guide to پۆتاسیومی بەرزبووی کەم.
Protein targets change with CKD stage and dialysis
Protein needs differ sharply between non-dialysis CKD and dialysis. Many metabolically stable adults with CKD G3–G5 not receiving dialysis are prescribed about 0.6–0.8 g/kg/day, whereas haemodialysis commonly requires 1.0–1.2 g/kg/day to offset amino-acid losses.
The 2020 KDOQI nutrition guideline supports protein restriction under dietitian supervision for selected adults with CKD who are metabolically stable (Ikizler et al., 2020). For a 70 kg person, 0.8 g/kg/day is roughly 56 g daily—not “avoid protein,” and not a reason to eliminate legumes automatically.
Protein-energy wasting changes the equation. Unintentional loss of more than 5% of body weight in 3 months, reduced appetite, albumin interpreted alongside inflammation, or frailty should prompt renal dietitian assessment rather than tighter protein limits. Our . explains why serum albumin is not a direct food diary.
A custom meal plan blood test workflow should ask about dialysis type, pregnancy, active wounds, cancer treatment, infection, exercise volume, and body-weight trend before calculating protein. A 62-year-old on peritoneal dialysis with poor appetite needs a more protein-dense plan than a sedentary person with G3a CKD; the same eGFR number would mislead you.
Plant protein is not automatically forbidden
Plant proteins can fit CKD eating patterns, but serving size, potassium, phosphate additives, diabetes control, and protein target matter. The clinical goal is adequate nutrition with lower renal burden where appropriate, not a simplistic animal-versus-plant contest.
Phosphate, calcium and PTH need a connected reading
Persistent phosphate above about 1.45 mmol/L (4.5 mg/dL) in advanced CKD deserves review, but one modest elevation does not prove dietary excess. Kidney mineral-bone disorder is interpreted through phosphate, corrected calcium, parathyroid hormone, vitamin D therapy, kidney stage, and binder timing.
Phosphate from additives is usually absorbed more efficiently than phosphate naturally present in grains, beans, nuts, or dairy. An AI nutritionist should first flag ingredient patterns and ask about phosphate binders rather than reflexively cutting nutritious plant foods. Our article on phosphate بەرز دەکاتەوە covers the relevant non-diet causes.
Corrected calcium formulas are imperfect when albumin is low, and ionized calcium may be more informative in selected acute situations. Calcium-based binders, calcitriol, and vitamin D supplements can shift calcium and phosphate in opposite directions, which is why meal advice cannot be separated from prescription review.
Dr. Thomas Klein has seen patients stop all dairy after seeing phosphate 1.5 mmol/L, then replace it with processed snacks containing phosphate additives. The more useful question is whether phosphate is persistently high across 2–3 tests, whether PTH is rising, and whether the prescribed binder is being taken with meals as directed.
Bicarbonate, sodium and fluid status alter the food plan
Serum bicarbonate below 22 mmol/L in CKD suggests metabolic acidosis and merits clinician review because it can accelerate muscle breakdown and bone effects. Sodium reduction helps blood pressure and fluid balance, but fluid restriction is usually based on oedema, urine output, sodium, heart status, and dialysis prescription—not eGFR alone.
KDIGO 2024 suggests sodium intake below 2 g/day, roughly 5 g of salt daily, for most people with CKD. The largest sodium source is often packaged bread, sauces, convenience food, and restaurant meals rather than the salt shaker; a DASH laboratory guide can help with practical swaps.
Low bicarbonate can coexist with a normal potassium result, so it should not be overlooked in a blood test based diet. Fruit and vegetable strategies may benefit some patients, but advanced CKD, hyperkalaemia risk, and diabetes medicines can make an unsupervised “alkaline diet” unsafe.
Swelling is not proof that a person drank too much water. New ankle swelling with low albumin, rising creatinine, breathlessness, or rapid weight gain needs assessment for cardiac, renal, liver, or venous causes; our swelling lab guide outlines the overlap.
Why urine ACR often matters more than creatinine alone
A urine albumin-creatinine ratio (ACR) below 30 mg/g is A1, 30–300 mg/g is A2, and above 300 mg/g is A3 albuminuria. ACR detects kidney damage and cardiovascular risk that a creatinine-based eGFR may miss, particularly early in diabetes or hypertension.
A first raised ACR should be repeated, preferably using an early morning collection, because fever, vigorous exercise, urinary infection, menstruation, and marked hyperglycaemia can transiently increase albumin excretion. Our practical ئامادەکردنی ACR details avoidable pre-test errors.
Kantesti AI reads ACR alongside eGFR and blood pressure-related markers to identify where food advice should not distract from medication optimisation. Kantesti ئامرازێکی شیکردنەوەی تاقیکردنەوەی خوێنە بە پشتگیری AI that can surface an ACR trend from uploaded reports, but urine dipstick protein, ACR, and 24-hour collections are not interchangeable tests.
For diet design, persistent A3 albuminuria may strengthen discussion of sodium, diabetes management, blood-pressure targets, and ACE inhibitor or ARB adherence. It does not automatically justify severe potassium, phosphate, or fluid restriction when those values are normal.
Medication lists can overrule generic food advice
ACE inhibitors, ARBs, mineralocorticoid receptor antagonists, SGLT2 inhibitors, diuretics, insulin, phosphate binders, and potassium supplements each change how kidney labs should be read. Any meal plan that lacks a current medication list can be unsafe.
ACE inhibitors and ARBs may cause a modest early creatinine rise while lowering albuminuria over time; an eGFR fall after an SGLT2 inhibitor can also be an expected haemodynamic dip. The correct response is usually scheduled monitoring, not stopping a kidney-protective medicine or over-restricting food; see eGFR changes with SGLT2 drugs.
Potassium-based salt substitutes are a frequent blind spot in people taking ACE inhibitors, ARBs, or spironolactone. They may lower sodium exposure yet push potassium upward, particularly when eGFR is below 45 mL/min/1.73 m².
NSAIDs deserve particular caution: ibuprofen, naproxen, and similar products can worsen kidney perfusion, raise potassium, and blunt diuretics. An AI should ask about over-the-counter products and herbal preparations, since patients often do not classify them as medicines.
Why lab trends matter more than a single kidney result
A meaningful kidney trend needs comparable tests, dates, units, and clinical context. Creatinine, potassium, and urea can change after illness, dehydration, a hard workout, steroid use, or a change in laboratory method; interpreting them without timing produces false dietary restrictions.
When I review a creatinine increase from 88 to 103 µmol/L, I ask first about timing: was the person fasting, dehydrated, febrile, taking creatine, or tested after heavy exercise? A repeat under ordinary conditions can be more informative than changing the entire diet that afternoon. Read کراتینین بعد از ورزش.
Kantesti’s trend analysis compares dated values and preserves original units, making it easier to see whether potassium moved 0.1 mmol/L or 0.8 mmol/L. Our lab-change explainer also discusses reference change value—the often-missed idea that some small shifts are analytical noise.
The most useful repeat schedule varies. A medication change with potassium risk may require testing in 1–2 weeks, whereas stable G3a CKD may be monitored every 6–12 months; the treating team sets this based on risk, not an app.
What laboratory data cannot tell an AI nutritionist
Laboratory results cannot measure appetite, food access, chewing ability, cultural staples, cooking skills, frailty, or whether a person can afford the suggested food. They also cannot determine the cause of kidney disease from routine chemistry alone.
A potassium result cannot tell whether high values came from salt substitute, constipation, missed dialysis, metabolic acidosis, a medication interaction, or a flawed collection. A low albumin result cannot tell whether dietary intake is poor, inflammation is present, fluid overload diluted the sample, or liver disease contributes.
This is where a personalized nutrition plan must invite correction rather than claim certainty. A person who relies on lentils, cassava, rice, maize, flatbreads, tofu, fish, or local vegetables needs portion-based adaptations that maintain calories and identity, not a transplant from a generic Western renal menu.
Kantesti supports 75+ languages and can make laboratory reports easier to discuss across households, but it does not replace shared decision-making. Our family lab-sharing guidance covers consent before relatives view another person’s results.
A safer workflow for building kidney-friendly meals with AI
The safest AI workflow has five steps: verify the report, identify kidney stage and urine ACR, reconcile medicines, set clinician-approved targets, and retest after changes. Skipping the medication or symptom check is the commonest route to unsafe generic advice.
Start with a clear report that includes collection date, units, reference intervals, creatinine, eGFR, potassium, bicarbonate, calcium, phosphate, glucose or HbA1c, and urine ACR when available. PDF extraction errors occur, especially with decimal points and units; use our OCR verification checklist before acting on a result.
Then tell the system about dialysis, transplant, pregnancy, diabetes, blood pressure, weight change, bowel pattern, food allergies, and every prescription and supplement. This turns recipe suggestions into bounded options: for example, “lower-sodium lunch choices pending potassium review,” rather than “eat this daily.”
Kantesti uses privacy-focused, GDPR-aligned handling for uploaded reports and returns an interpretation in roughly 60 seconds, but clinical decisions remain with the person’s care team. For methodology and oversight, review our technical validation approach.
When a low-potassium diet can cause harm
A low-potassium diet can harm people who have normal potassium, poor appetite, constipation, diabetes, or high cardiovascular risk by unnecessarily reducing fibre-rich foods. Potassium restriction should be targeted to laboratory elevation and clinical circumstances, not automatically assigned to every CKD stage.
Many potassium-rich foods also provide fibre, folate, vitamin C, magnesium, and plant protein. Removing them indiscriminately can worsen constipation—which itself may increase potassium—and can make glycaemic control harder if they are replaced with refined starches.
Cooking technique offers a middle ground. For some vegetables, boiling in ample water and discarding the water reduces potassium more than steaming; yet the real benefit depends on portion size and total daily intake, so the method should follow a prescribed target.
The same caution applies to supplements. “Kidney cleanse” powders, magnesium-containing laxatives, and potassium electrolyte drinks can be risky in reduced kidney function; see our CKD supplement safety guide.
Red flags that need a clinician, not an algorithm
Potassium 6.0 mmol/L or higher, a rapid eGFR decline, severe breathlessness, confusion, chest symptoms, fainting, or sharply reduced urine output require urgent human assessment. An AI nutritionist can identify these triggers but must not attempt to manage them through food advice.
Seek same-day medical advice for potassium 5.5–5.9 mmol/L when there is CKD, relevant medication use, symptoms, or a rising trend; the local clinician may advise an urgent repeat, ECG, medication adjustment, or emergency assessment. Potassium of 6.5 mmol/L or higher is often treated as an emergency threshold, though local protocols differ.
An abrupt creatinine rise, new blood in urine, fever with flank discomfort, or rapidly developing oedema needs diagnosis before dietary fine-tuning. Possible causes include obstruction, infection, immune disease, medication injury, and reduced kidney perfusion; food is rarely the whole explanation.
Dr. Thomas Klein advises patients to keep a dated medication list and the original laboratory PDF for urgent review. If uncertainty remains, our لیستی چەککردنی دووەم-بینی can help prepare focused questions for a clinician.
Questions to take to your renal clinician or dietitian
The best kidney diet questions are specific: Which target applies to me, which result is changing, and when should it be rechecked? A renal dietitian can translate these answers into portions, cooking methods, and meals that meet calorie and protein needs.
Ask whether your eGFR change is persistent, whether urine ACR has been checked, and whether potassium, bicarbonate, phosphate, and calcium need dietary action now. Ask for targets in your report’s units; “watch potassium” is less actionable than “keep potassium under 5.2 mmol/L until retesting in 10 days.”
Bring a 3-day food record including drinks, salt substitutes, protein powders, laxatives, and herbal products. The record often reveals hidden sodium or potassium additives more clearly than a memory-based interview, and it helps preserve foods you actually enjoy.
Our doctors review clinical safety principles behind Kantesti content, while individual care remains with your own team. You can see the relevant clinical governance on our لاپەڕەی Medical Advisory Board, and use the discussion to make your next consultation more efficient.
Bottom line: use labs as guardrails, not food rules
Lab-guided kidney nutrition works best when labs act as guardrails: eGFR and ACR define risk, potassium and bicarbonate define immediate safety, and medicines explain many changes. The final meal plan should protect nutrition, quality of life, and kidney safety at the same time.
A blood test based diet is strongest when it uses at least two time points, current medicines, urine data, and symptoms. It is weakest when it turns one creatinine value into a long ban list. For additional context on structured lab interpretation, see our چکلیست ایمنی گزارشِ AI.
In practice, most people do better with a small number of changes: replace high-sodium packaged meals, avoid potassium salt substitutes if at risk, match protein to CKD or dialysis status, and repeat the relevant tests on schedule. That is less glamorous than a “perfect renal menu,” but it is how safe care tends to work.
Kantesti is an AI lab test interpretation service that helps users organise questions from laboratory trends for their clinician; it does not prescribe treatment. For a transparent explanation of how our analysis works, see the ڕێنمایی تەکنەلۆژیای AI.
Pirsên Pir tên Pirsîn
ئایا زیرهکی دهستکرد دهتوانێت رێجیمی خۆراکی گورچیله بهپێی پشکنینی خوێن دروست بکات؟
دروستکردنی چوارچێوەیەکی خۆراکی سەرەتایی دۆستانە بۆ گورچیلە لەلایەن پسپۆڕێکی خۆراک بە یارمەتی زیرەکی دەستکردەوە لە ئەنجامی تاقیکاری دووبارەبووەوە دروست دەکرێت، بەڵام ناتوانێت بە سەلامەتی ڕێنمایی خۆراکێکی گورچیلە لە تاقیکردنەوەیەکی خوێن تەنها پێشکەش بکات. eGFR، پۆتاسیۆم، بایکربۆنات، فۆسفات، شیکاری میز (ACR)، لیستی دەرمانەکان، باری دیالیز، ئاڕاستەی کێش، و نیشانەکان هەموویان کاریگەرییان لەسەر پلانێکی گونجاو هەیە. بۆ نموونە، پۆتاسیۆمی 5.6 mmol/L لەوانەیە پێویستی بە دەرمان و پشکنینی دووبارە بکات، لەکاتێکدا پۆتاسیۆمی 4.4 mmol/L بەزۆری جێگای رێگیریی خۆراکێکی کەم پۆتاسیۆم نییە. پسپۆڕێکی نەخۆشیی گورچیلە یان ڕاهێنەری خۆراک دەبێت پشتڕاست کردنەوەی ڕێگریی مانادار لە پڕۆتین، شلەمەنی، پۆتاسیۆم، یان فۆسفات بکات.
چ eGFR پێویستی بە رێجیمی گورچیلە هەیە؟
هیچ بەهایەکی eGFR بە تەنها پێویستی بە رێجیمی قورسی گورچیلە نابێت. مانەوەی eGFR لە خوار 60 mL/min/1.73 m² بۆ ماوەی 3 مانگ یارمەتی دەدات بۆ پشتڕاستکردنەوەی CKD، بەڵام ئامانجەکانی رێجیمەکە پشت بە ACRی میز، پۆتاسیۆم، فاسفیت، بایکربۆنات، شەکرە، پەستانی خوێن، مەترسی سوءتێکچوون، و ئەگەر هەیەلوولەی dialysis بەکاردەهێنرێت، دەبەستێت. CKD G3a بریتییە لە eGFR 45–59 mL/min/1.73 m²، لەکاتێکدا G4 بریتییە لە 15–29 mL/min/1.73 m². کەسێک کە G3a ی هەیە و پۆتاسیۆمی ئاساییە، لەوانەیە پێویستی بە کەمکردنەوەی سۆدیۆم و پرۆتینی پێویست بێت، نەک قەدەغەکردنی گشتگیر بۆ خواردن.
لە چ ئاستێکی پۆتاسیۆمدا دەبێت خۆم لە خواردنی ئەو خۆراکانەی پۆتاسیۆمیان زۆرە بپارێزم؟
Persistent potassium above 5.0–5.5 mmol/L may lead a clinician to individualise potassium intake, particularly when eGFR is reduced or potassium-raising medicines are used. Potassium of 6.0 mmol/L or higher needs urgent clinical assessment rather than self-treatment through dietary changes. A falsely high result can occur with sample haemolysis, so a repeat collection may be necessary when the result conflicts with the clinical picture. Do not use potassium-based salt substitutes without clinical advice if you have CKD or take an ACE inhibitor, ARB, or spironolactone.
ڕێژەی پرۆتینی پێویست بۆ کەسێک کە نەخۆشیی درێژخایەنی گورچیلەی (CKD) هەیە چەندە؟
زۆرێک لە گەورەپیاوانی خاوەن CKD کە لەڕووی میتابۆلیزمییەوە جێگیرن و دیالیز وەرناگرن، ڕێنمایی دەکرێن کە ڕۆژانە نزیکەی 0.6–0.8 گرام پ ر ۆتین لە هەر کیلۆیەک کێشی لەشیان بخۆن، بەڵام دەبێت ئامانجەکە بە تاک تاک بکرێت. گەور ە پیاوێکی 70 کیل ۆ گرمیی ش کە بە ڕێژەی 0.8 گرام/کیل ۆ /ڕۆژانە، نزیکەی 56 گرام پ ر ۆتین لە ڕۆژێکدا دەخ و ات. ئەوانەی هێمۆدیالیز وەردەگرن بە شێوەیەکی گشتی پێویستیان بە 1.0–1.2 گرام/کیل ۆ /ڕۆژانە هەیە چونک ە دیالیز ئ ەمینۆ ئەسیدەکان ل ا ئەبات. دووگیانی، لاوازی، نەخۆشی چالاک، دابەزینی کێش، و کەمب ۆ نی و خواردن دە ت وانێت پ ێویستی پ ر ۆتین زیاد بکات و پێو ی ستی بە ڕاوێژی پسپ ۆ ڕی خۆراک هەیە.
ئایا دەتوانم میوە و سەوزە بخۆم لەگەڵ نەخۆشیی درێژخایەنی گورچیلە؟
زۆربەی ئەو کەسانەی نەخۆشی درێژخایەنی گورچیلەیان هەیە دەتوانن میوە و سەوزە بخۆن، و زۆربەیان پێویستیان بە رێجیمی کەم پۆتاسیۆم نییە. سنوردارکردن بە گشتی کاتێک گرنگ دەبێت کە پۆتاسیۆم بەردەوام بەرز بێت، زۆرجار لە 5.0–5.5 mmol/L زیاتر بێت، یان کاتێک پزیشکی گورچیلە مەترسییەکی بەرز دیاری دەکات. قەبارەی بەش، شێوازی ئامادەکردن، قەبزی، حاڵەتی ترش-بنەمایی، دەرمانەکان، و زیادکراوەکانی پۆتاسیۆم زیاتر گرنگن لە تەنها ناونیشانکردنی خۆراکەکان وەک باش یان خراپ. جێگرتنەوەی هەموو بەرهەمەکان بە خۆراکی ئاوێتە دەتوانێت ڕێژەی ڕیشاڵ کەم بکاتەوە و کوالێتی گشتی خۆراک خراپتر بکات.
کام تاقیکردنەوەی گورچیلەکان هەڵبگرم بۆ پلانێکی خۆراکی تایبەت؟
A useful kidney nutrition review includes creatinine, eGFR, potassium, sodium, bicarbonate or total CO2, calcium, phosphate, urea or BUN, glucose or HbA1c, and urine ACR when available. Include at least two dated reports when possible because a creatinine change from 80 to 100 µmol/L may be temporary or clinically meaningful depending on timing and context. The medication list, dialysis status, blood pressure, body weight, and food pattern are equally necessary. A plan based only on a creatinine result is incomplete.
ئەمڕۆ AI-پاوەرد لەسەر تاقیکردنەوەی خوێن بەدەست بهێنە
بە یارمەتی زیاتر لە 2 ملیۆن بەکارهێنەر لە هەموو جیهاندا کە Kantesti دەستپێدەکەن بۆ تاقیکردنەوەی لابراتۆری ڕاست و بەهێز لە کاتێکی کەم. ڕەخنەی تاقیکردنەوەی خوێنت بنێرە و تفسیرێکی تەواو لە 15,000+ نیشانەی زیستی (biomarkers) لە ماوەی چرکەکاندا وەرگرە.
📚 توێژینەوە سەرچاوە پەیوەندیدارەکان
Klein, T., Mitchell, S., & Weber, H. (2026). Rêzeya Normal a aPTT: D-Dimer, Rêbernameya Mêjkirina Xwînê ya Proteîna C. Kantesti توێژینەوەی پزیشکی AI.
Klein, T., Mitchell, S., & Weber, H. (2026). Rêbernameya Proteînên Serumê: Testa Xwînê ya Globulîn, Albumîn û Rêjeya A/G. Kantesti توێژینەوەی پزیشکی AI.
📖 سەرچاوەی پزیشکی دەرەکی
⚕️ Daxuyaniya Bijîşkî
ئەم مادەیە تەنها بۆ. I think I must continue but user expects all items.
E-E-A-T Trust Signals
Tecribe
Physician-led clinical review of lab interpretation workflows.
Pisporî
Laboratory medicine focus on how biomarkers behave in clinical context.
Desthilatdarî
Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.
Bawerî
Evidence-based interpretation with clear follow-up pathways to reduce alarm.